MiR-126 and miR-126 * repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis

Nature Cell Biology

Volumn 15, Issue 3, 2013, Pages 284-294

  Zhang, Yun ^a   Yang, Pengyuan ^a   Sun, Tao ^a   Li, Dong ^b,f   Xu, Xin ^a   Rui, Yaocheng ^b   Li, Chaoran ^a   Chong, Mengyang ^a   Ibrahim, Toni ^c   Mercatali, Laura ^c   Amadori, Dino ^c   Lu, Xincheng ^d   Xie, Dong ^e   Li, Qi Jing ^a   Wang, Xiao Fan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^d WENZHOU MEDICAL UNIVERSITY   (China)

^e Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^f CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 126; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INVASION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EGFL7 GENE; EPIGENETICS; FEMALE; GENETIC CORRELATION; LUNG METASTASIS; MESENCHYMAL STEM CELL; METASTASIS FREE SURVIVAL; METHYLATION; MOLECULAR PATHOLOGY; MONOCYTE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN TARGETING; TUMOR MICROENVIRONMENT;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL12; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INFLAMMATION; LUNG NEOPLASMS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICRORNAS; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84874629992     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2690     Document Type: Article

References (47)

1. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108 (2005).
2. Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organ-speci-c colonization. Nat. Rev. Cancer 9, 274-284 (2009).
3. Valastyan, S. & Weinberg, R. A. Tumour metastasis: molecular insights and evolving paradigms. Cell 147, 275-292 (2011).
4. Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559-1564 (2011).
5. Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumour microenvironment. Cancer Cell 21, 309-322 (2012).
6. Orimo, A. et al. Stromal-broblasts present in invasive human breast carcinomas promote tumour growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005).
7. Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563 (2007).
8. Li, H. J., Reinhardt, F., Herschman, H. R. & Weinberg, R. A. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov. 2, 840-855 (2012).
9. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
10. Joyce, J. A. & Pollard, J. W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252 (2009).
11. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
12. Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. & Calin, G. A. MicroRNAs-the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293-302 (2009).
13. Kasinski, A. L. & Slack, F. J. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 11, 849-864 (2011).
14. Volinia, S. et al. A microRNA expression signature of human solid tumours de-nes cancer gene targets. Proc. Natl Acad. Sci. USA 103, 2257-2261 (2006).
15. Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688 (2007).
16. Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-U143 (2008).
17. Png, K. J., Halberg, N., Yoshida, M. & Tavazoie, S. F. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481, 190-194 (2012).
18. Crawford, M. et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 373, 607-612 (2008).
19. Dong, M. et al. The type III TGF-beta receptor suppresses breast cancer progression. J. Clin. Invest. 117, 206-217 (2007).
20. Yang, P. et al. TGF-beta-miR-34a-CCL22 signaling-induced treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22, 291-303 (2012).
21. Miranda, K. C. et al. A pattern-based method for the identi-cation of microRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217 (2006).
22. Betel, D., Wilson, M., Gabow, A., Marks, D. S. & Sander, C. The microRNA.org resource: targets and expression. Nucl. Acids Res. 36, D149-D153 (2008).
23. Kim, V. N., Han, J. & Siomi, M. C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139 (2009).
24. Stenvang, J., Petri, A., Lindow, M., Obad, S. & Kauppinen, S. Inhibition of microRNA function by antimiR oligonucleotides. Silence 3, 1 (2012).
25. Kryczek, I. et al. CXCL12 and vascular endothelial growth factor synergistically in-duce neoangiogenesis in human ovarian cancers. Cancer Res. 65, 465-472 (2005).
26. Aiuti, A., Webb, I. J., Bleul, C., Springer, T. & GutierrezRamos, J. C. The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood. J. Exp. Med. 185, 111-120 (1997).
27. Ponte, A. L. et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25, 1737-1745 (2007).
28. Kitaori, T. et al. Stromal cell-derived factor 1/CXCR4 signalling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum. 60, 813-823 (2009).
29. Son, B. R. et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24, 1254-1264 (2006).
30. Soleimani, M. & Nadri, S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat. Protoc. 4, 102-106 (2009).
31. Broxmeyer, H. E. et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201, 1307-1318 (2005).
32. Fox, J. M., Chamberlain, G., Ashton, B. A. & Middleton, J. Recent advances into the understanding of mesenchymal stem cell traf-cking. Br. J. Haematol. 137, 491-502 (2007).
33. Meirelles Lda, S. & Nardi, N. B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br. J. Haematol. 123, 702-711 (2003).
34. Baddoo, M. et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell Biochem. 89, 1235-1249 (2003).
35. Qian, B. Z. et al. CCL2 recruits in-ammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222-225 (2011).
36. Aslakson, C. J. & Miller, F. R. Selective events in the metastatic process de-ned by analysis of the sequential dissemination of subpopulations of a mouse mammary tumour. Cancer Res. 52, 1399-1405 (1992).
37. Saito, Y. et al. Epigenetic therapy upregulates the tumour suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem. Biophys. Res. Commun. 379, 726-731 (2009).
38. Marchesi, F. et al. Increased survival, proliferation, and migration in metastatic human pancreatic tumour cells expressing functional CXCR4. Cancer Res. 64, 8420-8427 (2004).
39. Miao, Z. et al. CXCR7 (RDC1) promotes breast and lung tumour growth in vivo and is expressed on tumour-associated vasculature. Proc. Natl Acad. Sci. USA 104, 15735-15740 (2007).
40. Kedde, M. et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131, 1273-1286 (2007).
41. Kedde, M. et al. A Pumilio-induced RNA structure switch in p27-30 UTR controls miR-221 and miR-222 accessibility. Nat. Cell Biol. 12, 1014-1020 (2010).
42. Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721-726 (2007).
43. Ma, C. et al. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 22, 308-321 (2008).
44. Rubin, J. B. et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumours. Proc. Natl Acad. Sci. USA 100, 13513-13518 (2003).
45. Chi, S. W., Zang, J. B., Mele, A. & Darnell, R. B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460, 479-486 (2009).
46. Ule, J. et al. CLIP identi-es Nova-regulated RNA networks in the brain. Science 302, 1212-1215 (2003).
47. Li, L. C. & Dahiya, R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 18, 1427-1431 (2002).